[1] ENGIN A. The Pathogenesis of Obesity-Associated Adipose Tissue Inflammation
[J]. Adv Exp Med Biol, 2017, 960: 221-45.

[2] ANDERSSON D P, ARNER E, HOGLING D E, et al. Abdominal subcutaneous adipose tissue cellularity in men and women
[J]. Int J Obes (Lond), 2017, 41(10): 1564-9.

[3] WANG Q A, TAO C, GUPTA R K, et al. Tracking adipogenesis during white adipose tissue development, expansion and regeneration
[J]. Nat Med, 2013, 19(10): 1338-44.

[4] VISHVANATH L, MACPHERSON K A, HEPLER C, et al. Pdgfrbeta+ Mural Preadipocytes Contribute to Adipocyte Hyperplasia Induced by High-Fat-Diet Feeding and Prolonged Cold Exposure in Adult Mice
[J]. Cell Metab, 2016, 23(2): 350-9.

[5] ZHU Q, AN Y A, KIM M, et al. Suppressing adipocyte inflammation promotes insulin resistance in mice
[J]. Mol Metab, 2020, 39: 101010.

[6] CATALDI S, APRILE M, MELILLO D, et al. TNFalpha Mediates Inflammation-Induced Effects on PPARG Splicing in Adipose Tissue and Mesenchymal Precursor Cells
[J]. Cells, 2021, 11(1).

[7] YE R Z, RICHARD G, GEVRY N, et al. Fat Cell Size: Measurement Methods, Pathophysiological Origins, and Relationships With Metabolic Dysregulations
[J]. Endocr Rev, 2022, 43(1): 35-60.

[8] SUN K, WERNSTEDT ASTERHOLM I, KUSMINSKI C M, et al. Dichotomous effects of VEGF-A on adipose tissue dysfunction
[J]. Proc Natl Acad Sci U S A, 2012, 109(15): 5874-9.

[9] FANG H, JUDD R L. Adiponectin Regulation and Function
[J]. Compr Physiol, 2018, 8(3): 1031-63.

[10] ZHU Q, SCHERER P E. Immunologic and endocrine functions of adipose tissue: implications for kidney disease
[J]. Nat Rev Nephrol, 2018, 14(2): 105-20.

[11] ACQUARONE E, MONACELLI F, BORGHI R, et al. Resistin: A reappraisal
[J]. Mech Ageing Dev, 2019, 178: 46-63.

[12] FASSHAUER M, BLUHER M. Adipokines in health and disease
[J]. Trends Pharmacol Sci, 2015, 36(7): 461-70.

[13] YORE M M, SYED I, MORAES-VIEIRA P M, et al. Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects
[J]. Cell, 2014, 159(2): 318-32.

[14] HAMMARSTEDT A, SYED I, VIJAYAKUMAR A, et al. Adipose tissue dysfunction is associated with low levels of the novel Palmitic Acid Hydroxystearic Acids
[J]. Sci Rep, 2018, 8(1): 15757.

[15] NGUYEN T D, WATANABE A, BURLEIGH S, et al. Monobutyrin and monovalerin improve gut-blood-brain biomarkers and alter gut microbiota composition in high-fat fed apolipoprotein-E-knockout rats
[J]. Sci Rep, 2022, 12(1): 15454.

[16] XIA J Y, HOLLAND W L, KUSMINSKI C M, et al. Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis
[J]. Cell Metab, 2015, 22(2): 266-78.

[17] SANCHEZ-RAMIREZ E, UNG T P L, ALARCON DEL CARMEN A, et al. Coordinated metabolic transitions and gene expression by NAD+ during adipogenesis
[J]. J Cell Biol, 2022, 221(12).

[18] ZHAO J, ZHOU A, QI W. The Potential to Fight Obesity with Adipogenesis Modulating Compounds
[J]. Int J Mol Sci, 2022, 23(4).

[19] GAO Z, DAQUINAG A C, SU F, et al. PDGFRalpha/PDGFRbeta signaling balance modulates progenitor cell differentiation into white and beige adipocytes
[J]. Development, 2018, 145(1).

[20] GUPTA R K, ARANY Z, SEALE P, et al. Transcriptional control of preadipocyte determination by Zfp423
[J]. Nature, 2010, 464(7288): 619-23.

[21] ROH H C, KUMARI M, TALEB S, et al. Adipocytes fail to maintain cellular identity during obesity due to reduced PPARgamma activity and elevated TGFbeta-SMAD signaling
[J]. Mol Metab, 2020, 42: 101086.

[22] SCHUPP M, LAZAR M A. Endogenous ligands for nuclear receptors: digging deeper
[J]. J Biol Chem, 2010, 285(52): 40409-15.

[23] HALL J A, RAMACHANDRAN D, ROH H C, et al. Obesity-Linked PPARgamma S273 Phosphorylation Promotes Insulin Resistance through Growth Differentiation Factor 3
[J]. Cell Metab, 2020, 32(4): 665-75 e6.

[24] SONG T, KUANG S. Adipocyte dedifferentiation in health and diseases
[J]. Clin Sci (Lond), 2019, 133(20): 2107-19.

[25] LI H L, WU X, XU A, et al. A-FABP in Metabolic Diseases and the Therapeutic Implications: An Update
[J]. Int J Mol Sci, 2021, 22(17).

[26] PLIKUS M V, GUERRERO-JUAREZ C F, ITO M, et al. Regeneration of fat cells from myofibroblasts during wound healing
[J]. Science, 2017, 355(6326): 748-52.

[27] BLUHER M, MICHAEL M D, PERONI O D, et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance
[J]. Dev Cell, 2002, 3(1): 25-38.

[28] GHABEN A L, SCHERER P E. Adipogenesis and metabolic health
[J]. Nat Rev Mol Cell Biol, 2019, 20(4): 242-58.

[29] SON J W, KIM M K, PARK Y M, et al. Association of serum bone morphogenetic protein 4 levels with obesity and metabolic syndrome in non-diabetic individuals
[J]. Endocr J, 2011, 58(1): 39-46.

[30] HOKIMOTO S, FUNAKOSHI-TAGO M, TAGO K. Identification of DDX5 as an indispensable activator of the glucocorticoid receptor in adipocyte differentiation
[J]. FEBS J, 2022.

[31] HACKETT R A, STEPTOE A, KUMARI M. Association of diurnal patterns in salivary cortisol with type 2 diabetes in the Whitehall II study
[J]. J Clin Endocrinol Metab, 2014, 99(12): 4625-31.

[32] MANN J P, SAVAGE D B. What lipodystrophies teach us about the metabolic syndrome
[J]. J Clin Invest, 2019, 129(10): 4009-21.

[33] BROEKEMA M F, MASSINK M P G, DE LIGT J, et al. A Single Complex Agpat2 Allele in a Patient With Partial Lipodystrophy
[J]. Front Physiol, 2018, 9: 1363.

[34] PATNI N, VUITCH F, GARG A. Postmortem Findings in a Young Man With Congenital Generalized Lipodystrophy, Type 4 Due to CAVIN1 Mutations
[J]. J Clin Endocrinol Metab, 2019, 104(3): 957-60.

[35] LAVER T W, PATEL K A, COLCLOUGH K, et al. PLIN1 Haploinsufficiency Is Not Associated With Lipodystrophy
[J]. J Clin Endocrinol Metab, 2018, 103(9): 3225-30.

[36] SHIAU M Y, CHUANG P H, YANG C P, et al. Mechanism of Interleukin-4 Reducing Lipid Deposit by Regulating Hormone-Sensitive Lipase
[J]. Sci Rep, 2019, 9(1): 11974.

[37] RUBIO-CABEZAS O, PURI V, MURANO I, et al. Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC
[J]. EMBO Mol Med, 2009, 1(5): 280-7.

[38] ROHM M, ZEIGERER A, MACHADO J, et al. Energy metabolism in cachexia
[J]. EMBO Rep, 2019, 20(4).

[39] DUONG M N, GENESTE A, FALLONE F, et al. The fat and the bad: Mature adipocytes, key actors in tumor progression and resistance
[J]. Oncotarget, 2017, 8(34): 57622-41.

[40] WANG R, WEI L, WAZIR J, et al. Curcumin treatment suppresses cachexia-associated adipose wasting in mice by blocking the cAMP/PKA/CREB signaling pathway
[J]. Phytomedicine, 2023, 109: 154563.

[41] ZHANG Y, XIE Y, BERGLUND E D, et al. The starvation hormone, fibroblast growth factor-21, extends lifespan in mice
[J]. Elife, 2012, 1: e00065.

[42] DUTCHAK P A, KATAFUCHI T, BOOKOUT A L, et al. Fibroblast growth factor-21 regulates PPARgamma activity and the antidiabetic actions of thiazolidinediones
[J]. Cell, 2012, 148(3): 556-67.

[43] MEYER L K, CIARALDI T P, HENRY R R, et al. Adipose tissue depot and cell size dependency of adiponectin synthesis and secretion in human obesity
[J]. Adipocyte, 2013, 2(4): 217-26.

[44] YUAN Z, LI Q, LUO S, et al. PPARgamma and Wnt Signaling in Adipogenic and Osteogenic Differentiation of Mesenchymal Stem Cells
[J]. Curr Stem Cell Res Ther, 2016, 11(3): 216-25.